Home » Drug Information » Recently Approved Drugs » 1997
Medical Areas: Cardiology/Vascular Diseases
Drug Information
The following information is obtained from various newswires, published
medical journal articles, and medical conference presentations.
Company: Merck
Approval Status: Approved November 1997
Treatment Area: high triglyceride levels
Zocor (simvastatin) has been approved as a treatment for
lowering triglyceride levels in addition to its established role of
lowering total and LDL (bad) cholesterol in patients with both high
cholesterol and high triglycerides. Triglycerides are blood fats
that may be elevated in people with high cholesterol and heart
disease. In patients with high cholesterol alone or with high
cholesterol and triglycerides, Zocor is also indicated as
- An adjunct to diet to reduce triglycerides, as well as total
and LDL cholesterol levels
- A drug for reducing the risk of first stroke or transient
ischemic attack in people with high cholesterol and coronary artery
disease (those who are at the highest risk for cardiovascular
events)